Why is Crest Ventures falling/rising?

Sep 22 2025 09:21 PM IST
share
Share Via
As of 22-Sep, Crest Ventures Ltd's stock price is Rs 378.00, reflecting a decline of 0.63% and a significant drop of 35.76% over the past year. The stock's poor performance is attributed to disappointing financial results and high valuation concerns, leading to a lack of confidence from institutional investors.
As of 22-Sep, Crest Ventures Ltd is experiencing a decline in its stock price, currently at Rs 378.00, which reflects a decrease of Rs 2.4 or 0.63%. The stock has underperformed its sector by 0.56% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 2.9% during this period. Over the past week, the stock has shown a modest gain of 1.82%, but it has underperformed over the last month with a decline of 0.43%. The stock's performance year-to-date is significantly negative at -11.16%, and it has also seen a substantial drop of -35.76% over the past year, indicating ongoing challenges. Despite a healthy long-term growth rate in operating profit of 34.54%, negative results reported for June 25, including a 39.08% fall in profit before tax and a 48.4% decline in profit after tax, have contributed to investor concerns. Additionally, the stock's low inventory turnover ratio and a relatively high price-to-book value suggest that it may be overvalued compared to its peers.

In the broader market context, while the BSE500 index has generated negative returns of -3.80% over the past year, Crest Ventures' performance has been significantly worse, with a return of -35.76%. This stark contrast highlights the stock's underperformance relative to the market. Furthermore, the stock's liquidity appears adequate for trading, but the lack of domestic mutual fund investment, which stands at 0%, may indicate a lack of confidence from institutional investors. The stock is currently trading above its 20-day moving average but below its longer-term moving averages, suggesting mixed signals in terms of momentum. Overall, the combination of disappointing financial results, high valuation concerns, and weak institutional support has led to the stock's recent decline.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News